Harvey M. Golomb to Etoposide
This is a "connection" page, showing publications Harvey M. Golomb has written about Etoposide.
Connection Strength
0.055
-
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study. Chest. 1989 Jul; 96(1):110-3.
Score: 0.021
-
Chemotherapy of metastatic non-small cell bronchogenic carcinoma. Semin Oncol. 1983 Mar; 10(1):111-22.
Score: 0.014
-
VP16-213 in combined modality treatment of small cell carcinoma of the lung. Eur J Cancer Clin Oncol. 1982 Apr; 18(4):343-6.
Score: 0.013
-
Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report. Cancer. 1986 Jan 01; 57(1):44-53.
Score: 0.004
-
Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma. Cancer Treat Rep. 1984 Feb; 68(2):413-5.
Score: 0.004